Evaluation of a novel anti-ischemic agent in acute coronary syndromes: Design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non–ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial

Authors:
  • BSBenjamin M. Scirica
    Benjamin M. Scirica
  • EKEwa Karwatowska-Prokopczuk
    Ewa Karwatowska-Prokopczuk
  • ASAllan Skene
    Allan Skene
  • CMCarolyn H. McCabe
    Carolyn H. McCabe
  • EBEugene Braunwald
    Eugene Braunwald

Abstract
No abstract available

This publication has 25 references indexed in Scilit: